Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China

President Donald Trump signed Executive Order 14228, increasing tariffs from 10% to 20% on Chinese products in response to China's inadequate efforts to curb the flow of synthetic opioids, like fentanyl, into the U.S. This action aims to pressure China into taking more effective measures against the opioid crisis, which poses a significant threat to U.S. national security and economy. The order could escalate trade tensions between the two countries and has potential legal implications under international trade laws.